EZH2-targeted therapies in cancer: hype or a reality

ML Eich, M Athar, JE Ferguson III, S Varambally - Cancer research, 2020 - AACR
Next-generation genomic sequencing has identified multiple novel molecular alterations in
cancer. Since the identification of DNA methylation and histone modification, it has become …
被引用次数：176 相关文章

EZH2-Targeted Therapies in Cancer: Hype or a Reality

ML Eich, M Athar, JE Ferguson, S Varambally - Cancer Research, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Next-generation genomic sequencing has
identified multiple novel molecular alterations in cancer. Since the identification of DNA …
[HTML] nih.gov

[HTML][HTML] EZH2-targeted therapies in cancer: hype or a reality

ML Eich, M Athar, JE Ferguson III, S Varambally - Cancer research, 2020 - ncbi.nlm.nih.gov
Next-generation genomic sequencing has identified multiple novel molecular alterations in
cancer. Since the identification of DNA methylation and histone modification, it has become …

EZH2-Targeted Therapies in Cancer: Hype or a Reality

ML Eich, M Athar, JE Ferguson 3rd… - Cancer …, 2020 - pubmed.ncbi.nlm.nih.gov
Next-generation genomic sequencing has identified multiple novel molecular alterations in
cancer. Since the identification of DNA methylation and histone modification, it has become …

EZH2-Targeted Therapies in Cancer: Hype or a Reality.

ML Eich, M Athar, JE Ferguson 3rd… - Cancer …, 2020 - europepmc.org
Next-generation genomic sequencing has identified multiple novel molecular alterations in
cancer. Since the identification of DNA methylation and histone modification, it has become …
[PDF] websiteonline.cn

[PDF][PDF] EZH2-targeted therapies in cancer: hype or a reality

ML Eich, M Athar, JEF III… - Cancer …, 2020 - prod77d3c-pic14.websiteonline.cn
Next-generation genomic sequencing has identified multiple novel molecular alterations in
cancer. Since the identification of DNA methylation and histone modification, it has become …